nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Ad5CMVp53 gene therapy for locally advanced prostate cancer – where do we stand?
|
Sweeney, Paul |
|
2000 |
18 |
2 |
p. 121-124 |
artikel |
2 |
Adenovirus p16 gene therapy for prostate cancer
|
Allay, James A. |
|
2000 |
18 |
2 |
p. 111-120 |
artikel |
3 |
Antitumor efficacy of tumor-antigen-encoding recombinant poxvirus immunization in Dunning rat prostate cancer: implications for clinical genetic vaccine development
|
Charles, Linda G. |
|
2000 |
18 |
2 |
p. 136-142 |
artikel |
4 |
Antitumor efficacy of tumor-antigen-encoding recombinant poxvirus immunization in Dunning rat prostate cancer: implications for clinical genetic vaccine development
|
Charles, Linda G. |
|
|
18 |
2 |
p. 136-142 |
artikel |
5 |
B7-1 gene-modified autologous tumor-cell vaccines for renal-cell carcinoma
|
Antonia, Scott J. |
|
2000 |
18 |
2 |
p. 157-163 |
artikel |
6 |
Gene therapy for bladder cancer
|
Pagliaro, Lance C. |
|
2000 |
18 |
2 |
p. 148-151 |
artikel |
7 |
Gene therapy for prostate cancer at the University of California, Los Angeles: preliminary results and future directions
|
Pantuck, Allan J. |
|
2000 |
18 |
2 |
p. 143-147 |
artikel |
8 |
Gene therapy for prostate cancer at the University of California, Los Angeles: preliminary results and future directions
|
Pantuck, Allan J. |
|
|
18 |
2 |
p. 143-147 |
artikel |
9 |
Gene therapy in urologic oncology
|
Gingrich, Jeffrey R. |
|
2000 |
18 |
2 |
p. 91-92 |
artikel |
10 |
Intratumoral interleukin 2 for renal-cell carcinoma by direct gene transfer of a plasmid DNA/DMRIE/DOPE lipid complex
|
Hoffman, David M. J. |
|
2000 |
18 |
2 |
p. 152-156 |
artikel |
11 |
Osteocalcin-directed gene therapy for prostate-cancer bone metastasis
|
Koeneman, Kenneth S. |
|
2000 |
18 |
2 |
p. 102-110 |
artikel |
12 |
Prospects for herpes-simplex-virus thymidine-kinase and cytokine gene transduction as immunomodulatory gene therapy for prostate cancer
|
Hassan, Waleed |
|
2000 |
18 |
2 |
p. 130-135 |
artikel |
13 |
Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase gene
|
Shalev, Moshe |
|
2000 |
18 |
2 |
p. 125-129 |
artikel |
14 |
Transcriptionally regulated adenoviruses for prostate-specific gene therapy
|
Lu, Yi |
|
2000 |
18 |
2 |
p. 93-101 |
artikel |